TSE:LABS - MediPharm Labs Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: C$0.40
  • Forecasted Upside: 110.53 %
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.19
+0.30 (1.20%)

This chart shows the closing price for LABS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New MediPharm Labs Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for LABS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for LABS

Analyst Price Target is C$0.40
▲ +110.53% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for MediPharm Labs in the last 3 months. The average price target is C$0.40, with a high forecast of C$0.50 and a low forecast of C$0.35. The average price target represents a 110.53% upside from the last price of C$0.19.

This chart shows the closing price for LABS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 3 contributing investment analysts is to hold stock in MediPharm Labs.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
6/16/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/14/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/13/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/13/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 5 hold ratings
  • 0 sell ratings
6/11/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
9/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
11/8/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
12/8/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/16/2021Alliance Global PartnersDowngradeHoldC$0.35
11/16/2021Canaccord GenuityDowngradeSpeculative Buy ➝ HoldC$0.70 ➝ C$0.35
8/17/2021Canaccord GenuityLower Price TargetBuyC$0.75 ➝ C$0.70
8/17/2021Alliance Global PartnersLower Price TargetStrong-BuyC$1.00 ➝ C$0.80
5/19/2021Alliance Global PartnersLower Price TargetC$1.25 ➝ C$1.00
5/19/2021ATB CapitalLower Price TargetC$0.60 ➝ C$0.50
5/18/2021Alliance Global PartnersBoost Price TargetStrong-BuyC$1.00 ➝ C$1.25
5/18/2021ATB CapitalBoost Price TargetSector PerformC$0.50 ➝ C$0.60
5/18/2021Canaccord GenuityLower Price TargetStrong-BuyC$1.00 ➝ C$0.75
4/1/2021Canaccord GenuityLower Price TargetStrong-BuyC$1.75 ➝ C$1.00
4/1/2021Alliance Global PartnersLower Price TargetStrong-BuyC$2.00 ➝ C$1.25
11/2/2020Alliance Global PartnersReiterated RatingBuyC$2.00
10/6/2020Canaccord GenuityBoost Price TargetC$2.25 ➝ C$2.50
8/17/2020Pi FinancialLower Price TargetNeutralC$1.75 ➝ C$1.25
8/17/2020ATB CapitalLower Price TargetC$2.15 ➝ C$2.00
8/11/2020Pi FinancialSet Price TargetNeutralC$1.75
7/6/2020Canaccord GenuityReiterated RatingSpeculative BuyC$2.25
6/19/2020Pi FinancialDowngradeBuy ➝ NeutralC$4.00 ➝ C$1.75
6/19/2020AltaCorp CapitalDowngradeOutperform ➝ Sector PerformC$4.30 ➝ C$2.15
6/16/2020Pi FinancialSet Price TargetBuyC$4.00
4/1/2020Canaccord GenuityLower Price TargetC$6.75 ➝ C$4.50
3/31/2020Pi FinancialLower Price TargetBuyC$5.00 ➝ C$4.00
3/26/2020AltaCorp CapitalLower Price TargetC$7.50 ➝ C$5.25
3/25/2020Pi FinancialLower Price TargetBuyC$7.25 ➝ C$5.00
(Data available from 12/9/2016 forward)

News Sentiment Rating

0.07 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/13/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/12/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
7/12/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/11/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/10/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/10/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/9/2021
  • 1 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
12/9/2021

Current Sentiment

  • 1 very positive mentions
  • 7 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
MediPharm Labs logo
MediPharm Labs Corp., together with its subsidiaries, produces and sells pharmaceutical-grade cannabis oil and concentrates, and advance derivative products in Canada and Australia. It formulates, processes, packages, and distributes cannabis extracts and cannabinoid-based products. The company was founded in 2015 and is headquartered in Barrie, Canada.
Read More

Today's Range

Now: C$0.19
Low: C$0.19
High: C$0.20

50 Day Range

MA: C$0.26
Low: C$0.19
High: C$0.32

52 Week Range

Now: C$0.19
Low: C$0.19
High: C$1.00

Volume

589,176 shs

Average Volume

1,232,447 shs

Market Capitalization

C$50.23 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of MediPharm Labs?

The following sell-side analysts have issued stock ratings on MediPharm Labs in the last twelve months: Alliance Global Partners, ATB Capital, and Canaccord Genuity.
View the latest analyst ratings for LABS.

What is the current price target for MediPharm Labs?

3 Wall Street analysts have set twelve-month price targets for MediPharm Labs in the last year. Their average twelve-month price target is C$0.40, suggesting a possible upside of 110.5%. ATB Capital has the highest price target set, predicting LABS will reach C$0.50 in the next twelve months. Canaccord Genuity has the lowest price target set, forecasting a price of C$0.35 for MediPharm Labs in the next year.
View the latest price targets for LABS.

What is the current consensus analyst rating for MediPharm Labs?

MediPharm Labs currently has 3 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in LABS, but not buy more shares or sell existing shares.
View the latest ratings for LABS.

What other companies compete with MediPharm Labs?

How do I contact MediPharm Labs' investor relations team?

The company's listed phone number is 705 719 7425. The official website for MediPharm Labs is www.medipharmlabs.com.